Certara is the global leader in biosimulation. Since 2014, our customers, who use our software and tech-enabled services, have received 90% of new drug approvals by the FDA. We accelerate medicines by optimizing R&D productivity through model-informed drug development, regulatory science, and market access solutions. Our clients include 2,000+ global biopharmaceutical companies, leading academic institutions, and regulatory agencies across 62 countries.
Tripos: Revolutionizing Biosimulation with Certara
Tripos is a leading biosimulation company that has been revolutionizing the pharmaceutical industry since its inception. The company is a subsidiary of Certara, which is the global leader in biosimulation. Since 2014, Tripos has helped its customers receive 90% of new drug approvals by the FDA through its software and tech-enabled services.
At Tripos, we believe that optimizing R&D productivity through model-informed drug development, regulatory science, and market access solutions can accelerate medicines' development. Our clients include over 2,000 global biopharmaceutical companies, leading academic institutions and regulatory agencies across 62 countries.
Our team at Tripos comprises experts in various fields such as pharmacology, toxicology, clinical research and data analytics. We use our expertise to develop innovative solutions that help our clients bring their drugs to market faster while reducing costs.
One of our core strengths at Tripos is our ability to provide customized solutions tailored to meet each client's unique needs. We work closely with our clients to understand their specific requirements and develop bespoke solutions that address their challenges effectively.
Our software platforms are designed using cutting-edge technology that enables us to simulate complex biological systems accurately. This allows us to predict how drugs will interact with the human body before they are tested on humans or animals - saving time and resources while reducing risks associated with clinical trials.
We also offer consulting services where we provide expert advice on various aspects of drug development such as preclinical studies design optimization or regulatory compliance strategies for new product submissions.
At Tripos/Certara we pride ourselves on being at the forefront of innovation in biosimulation technology. Our commitment to excellence has earned us numerous accolades over the years from industry experts worldwide.
In conclusion, if you're looking for a partner who can help you optimize your R&D productivity through model-informed drug development or need expert advice on regulatory compliance strategies for new product submissions - look no further than Tripos/Certara!